Table 1 Immunohistochemical detection of Eag1 in tumours
From: Overexpression of Eag1 potassium channels in clinical tumours
Tumour type | Whole antibody | Recombinant PhoA scFv | ||
|---|---|---|---|---|
N | Positive | N | Positive | |
Oesophagus carcinoma | 8 | 8 | 12 | 8 |
Gastric carcinoma | 10 | 9 | 14 | 6 |
Colon carcinoma | 8 | 6 | 40 | 31 |
Hepatocellular carcinoma | 10 | 10 | 8 | 5 |
Gallbladder carcinoma | 5 | 4 | 1 | 1 |
Pancreatic carcinoma | 8 | 6 | 1 | 1 |
Renal cell carcinoma | 9 | 9 | 9 | 6 |
Transitional cell carcinoma | 9 | 8 | 6 | 4 |
Prostate carcinoma | 56 | 55 | 1 | 1 |
Cervical carcinoma | 9 | 7 | - | |
Endometrial carcinoma | 10 | 10 | - | |
Cystadenocarcinoma of the ovary | 10 | 10 | - | |
Breast carcinoma | 230 | 196 | 116 | 95 |
Bronchus carcinoma | 10 | 9 | 73 | 41 |
Thyroid papillary carcinoma | 9 | 9 | 3 | 2 |
Basalioma, spinalioma | 10 | 1 | - | |
Malignant melanoma | 59 | 22 | 1 | 1 |
Total | 470 | 378 (80%) | 286 | 202 (71%) |